Literature DB >> 19101239

Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.

William Clifford Roberts1, Travis James Vowels, Jong Mi Ko, John Edward Capehart, Shelley Anne Hall.   

Abstract

Three quinquagenarians who underwent insertion of a left ventricular assist device (LVAD) because of severe heart failure and for whom histologic examination of the left ventricular apical "core" (removed to insert the device) showed noncaseating giant cell granulomas typical of sarcoidosis are described. Later, cardiac transplantation showed widespread sarcoid granulomas in the walls of the right and left ventricles and ventricular septum in 2 patients and extensive scarring in the third patient in the absence of coronary narrowing. Previously, 11 patients who underwent cardiac transplantation because of cardiac sarcoidosis had been reported, and in 1 of these patients, diagnosis was also initially made by examination of the left ventricular core excised at the time of insertion of an LVAD. In conclusion, excision of a portion of left ventricular wall to enable insertion of a therapeutic device (LVAD) can also serve as the means of definitive diagnosis of the underlying cardiac condition.

Entities:  

Mesh:

Year:  2008        PMID: 19101239     DOI: 10.1016/j.amjcard.2008.08.053

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Disseminated malignancy after extracorporeal life support and left ventricular assist device, diagnosed by left ventricular apical core biopsy.

Authors:  Tine E Philipsen; Tom Vermeulen; Viviane M Conraads; Inez E Rodrigus
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-30

2.  Cardiac sarcoidosis diagnosed by histological assessment of a left ventricular apical core excised for insertion of a left ventricular assist device.

Authors:  Masahiro Ryugo; Hironori Izutani; Toru Okamura; Fumiaki Shikata; Masahiro Okura; Yuki Nakamura; Akiyoshi Oogimoto; Jitsuo Higaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-04

3.  Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnoses.

Authors:  William C Roberts; Carey Camille Roberts; Jong Mi Ko; Giovanni Filardo; John Edward Capehart; Shelley Anne Hall
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

4.  Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases.

Authors:  Osama Okasha; Felipe Kazmirczak; Ko-Hsuan Amy Chen; Afshin Farzaneh-Far; Chetan Shenoy
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

5.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

Review 6.  Management of Cardiac Sarcoidosis in 2020.

Authors:  Nisha Gilotra; David Okada; Apurva Sharma; Jonathan Chrispin
Journal:  Arrhythm Electrophysiol Rev       Date:  2020-12

Review 7.  Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.

Authors:  Nisha A Gilotra; Jan M Griffin; Noelle Pavlovic; Brian A Houston; Jessica Chasler; Colleen Goetz; Jonathan Chrispin; Michelle Sharp; Edward K Kasper; Edward S Chen; Ron Blankstein; Leslie T Cooper; Emer Joyce; Farooq H Sheikh
Journal:  J Card Fail       Date:  2021-07-11       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.